Adult Patients
Trial 1 was a prospective, open-label clinical trial conducted at two U.S. hospitals to assess the performance of the original BreathID test with the IDkit Hp One. The study was designed to assess the sensitivity and specificity of the test for determining the status of gastrointestinal infections with H. pylori compared to other methods (pre-therapy phase) and evaluate the ability of the system to monitor the efficacy of therapy for H. pylori (post-therapy phase).
The study enrolled 315 adult patients in the pre-therapy phase. The post-therapy phase included 77 patients who had been positive for infection and had undergone eradication therapy at least four weeks prior. Patients were evaluated by at least two of the following diagnostic methods: histology, rapid urease test (RUT), and for post-therapy patients, an FDA-cleared urea breath test (UBT).
For the pre-therapy phase, the performance of the BreathID test with the IDkit Hp One was compared to congruent results from two endoscopy biopsy-based methods (RUT and histology). Performance was also compared to each method individually. Table 2 shows the congruent results from the two endoscopy biopsy-based methods (RUT and histology) compared to the original BreathID results. Overall, the observed sensitivity of the original BreathID test with the IDkit Hp One was 100% (95% CI: 92.5; 100.0). Table 3 shows the comparison between the rapid urease test results and the BreathID results. Table 4 shows the comparison between the histology results and the BreathID results.
Table 2: Comparison of the Original BreathID Test to Congruent Endoscopic Tests (RUT and histological exam) Pre-Therapy | Original BreathID Test |
Congruent Endoscopic TestsH. pylori positive is defined as positive rapid urea test and positive histology. H. pylori negative is defined as negative rapid urea test and negative histology.
Sensitivity: 100% [95% CI (92.5, 100)] Specificity: 99.2% [95% CI (97.2, 99.9)] | Positive | Negative | Total |
Positive | 47 | 0 | 47 |
Negative | 2 | 251 | 253 |
Total | 49 | 251 | 300 |
Table 3: Comparison of the Original BreathID Test to Rapid Urease Test (RUT) Pre-Therapy | Original BreathID Test |
RUT | Positive | Negative | Total |
Positive | 50 | 0 | 50 |
Negative | 2 | 259 | 261 |
Total | 52 | 259 | 311 |
% positive agreement: 100% [95% CI (94.2, 100)]
% negative agreement: 99.2% [95% CI (97.3, 99.9)]
Table 4: Comparison of the Original BreathID Test to Histology Pre-Therapy | Original BreathID Test |
Histology | Positive | Negative | Total |
Positive | 47 | 2 | 49 |
Negative | 6 | 251 | 257 |
Total | 53 | 253 | 306 |
% positive agreement: 95.9% [95% CI (86.0, 99.5)]
% negative agreement: 97.7% [95% CI (95.0, 99.1)]
For the post-therapy phase, the performance of the original BreathID test with the IDkit Hp One was compared to results from two endoscopy biopsy-based methods (RUT and histology). The BreathID test results were also compared to each method individually. Table 5 shows the results from the two endoscopy biopsy-based methods (RUT and histology) compared to the original BreathID results.
Table 6 shows the comparison between the rapid urease test results and the BreathID results. Table 7 shows the comparison between the histology results and the BreathID results. Table 8 shows the comparison between the UBT post-therapy results and the BreathID results.
Table 5: Comparison of Original BreathID Test to Endoscopic Tests (RUT and Histology) Post-Therapy | Original BreathID Test |
Endoscopic Tests H. pylori positive is defined as positive RUT and positive Histology H. pylori negative is defined as negative RUT and negative Histology
% positive agreement: 100% [95% CI (60.7, 100)] % negative agreement: 100% [95% CI (86.1, 100)] | Positive | Negative | Total |
Positive | 6 | 0 | 6 |
Negative | 0 | 20 | 20 |
Total | 6 | 20 | 26 |
Table 6: Comparison of the Original BreathID Test to RUT Post-Therapy | Original BreathID Test |
RUT | Positive | Negative | Total |
Positive | 7 | 0 | 7 |
Negative | 0 | 21 | 21 |
Total | 7 | 21 | 28 |
% positive agreement: 100% [95% CI (65.2, 100)]
% negative agreement: 100% [95% CI (86.7, 100)]
Table 7: Comparison of the Original BreathID Test to Histology Post-Therapy | Original BreathID Test |
Histology | Positive | Negative | Total |
Positive | 6 | 0 | 6 |
Negative | 1 | 20 | 21 |
Total | 7 | 20 | 27 |
% positive agreement: 100% [95% CI (60.7, 100)]
% negative agreement: 95.2% [95% CI (76.2, 99.9)]
Table 8: Comparison of the Original BreathID Test to UBT Post-Therapy | Original BreathIDTest |
UBT | Positive | Negative | Total |
Positive | 14 | 1 | 15 |
Negative | 0 | 31 | 31 |
Total | 14 | 32 | 46 |
% positive agreement: 93.3% [95% CI (68.1, 99.8)]
% negative agreement: 100% [95% CI (90.8, 100)]
Table 9 compares the original BreathID to congruent results from the two biopsy-based methods (rapid urease test and histological exam) or the urea breath test.
Table 9: Comparison of the Original BreathID Test to Endoscopic Tests and/ or UBT Post-Therapy | Original BreathID Test |
Endoscopic Tests and UBT H. pylori positive is defined as either positive RUT and positive Histology, or positive UBT. H. pylori negative is defined as either negative RUT and negative Histology, or negative UBT.
% positive agreement: 95.2% [95% CI (76.2, 99.9)] % negative agreement: 100% [95% CI (94.2, 100)] | Positive | Negative | Total |
Positive | 20 | 1 | 21 |
Negative | 0 | 50 | 50 |
Total | 20 | 51 | 71 |
Trial 2 was a single-center, one-arm, blinded, comparative study conducted to demonstrate the clinical equivalence of the modified BreathID test with the IDkit Hp One compared to the original BreathID test with the IDkit Hp One. The study included a total of 79 adult patients who were connected simultaneously to both devices. The outcome measures of both devices were used for the comparison. Overall, the observed positive agreement of the BreathID test with the IDkit Hp One compared to the original BreathID test was 100% (95% CI: 81.6; 100.0). Table 10 details the comparison between both systems.
Table 10: Comparison of the Modified BreathID Test to the Original BreathID Test | Original BreathID Test |
Modified BreathID Test H. pylori positive is defined as positive on the original BreathID test.
% positive agreement: 100% [95% CI (81.6, 100)] % negative agreement: 96.8% [95% CI (89.0, 99.1)] | Positive | Negative | Total |
Positive | 17 | 2 | 19 |
Negative | 0 | 60 | 60 |
Total | 17 | 62 | 79 |
Pediatric Patients
Trial 3 was a multi-center, non-randomized, open-label study conducted to confirm the safety of the 13C-urea substrate in IDkit Hp One and evaluate the performance of the BreathID system device in pediatric patients from 3 years to less than 18 years old (NCT02528721). The study was designed to assess the performance of the BreathID system and IDkit Hp One with nasal cannula to detect H. pylori utilizing a 5 delta over baseline (DOB) diagnostic cut-off compared to an FDA-cleared H. pylori stool antigen test.
A total of 41 pediatric patients were enrolled in the study across 6 clinical sites. Table 11 presents the diagnosis as assessed by the BreathID system using IDkit Hp One compared to the assessment by an FDA cleared H. pylori stool antigen test.
Table 11: Comparison of the BreathID Test using IDkit Hp One to an FDA-cleared H. pylori stool antigen test | BreathID Test Using IDkit Hp One |
Stool Antigen | Positive | Negative | Total |
Positive | 14 | 1 | 15 |
Negative | 0 | 26 | 26 |
Total | 14 | 27 | 41 |
% positive agreement: 93.3% [95% CI (68.05, 99.83)]
% negative agreement: 100% [95% CI (86.77, 100)]